Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older A Systematic Review and Metaregression Analysis.
This systematic review and metaregression analysis estimates the association between the delta-9-tetrahydrocannabinol (THC) dose of cannabinoid-based medicines and neuropsychiatric adverse events among adults aged 50 years and older.